首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >The synthesis of three isotopomers of 2-methyl-2-(4-(3-(1-(4-methylbenzyl)-5-oxo-4,5-dihydro-lH-(l,2,4)triazol-3-yl)propyl)phenoxy)propionic acid, a potent and selective peroxisome proliferator-activated receptor alpha agonist
【24h】

The synthesis of three isotopomers of 2-methyl-2-(4-(3-(1-(4-methylbenzyl)-5-oxo-4,5-dihydro-lH-(l,2,4)triazol-3-yl)propyl)phenoxy)propionic acid, a potent and selective peroxisome proliferator-activated receptor alpha agonist

机译:2-甲基-2-(4-(3-(1-(4-甲基苄基)-5-氧代-4,5-二氢-1H-(1,2,4)三唑-3)三种异构体的合成丙基)苯氧基)丙酸,一种有效的选择性过氧化物酶体增殖物激活受体α激动剂

获取原文
获取原文并翻译 | 示例
           

摘要

Although fenofibrate (la) is commercially available and clinically effective in lowering serum triglycerides, its activity and sub-type selectivity at the PPARa receptors are only moderate; therefore, there exists a need for more potent and sub-type selective PPARa agonists. To that end, discovery efforts have identified 2-methyl-2-(4-[3-[l-(4-methylbenzyl)-5-oxo-4,5-dihydro-lH-[l,2,4]triazol-3-yl]propyl]phenoxy)propionic acid (2), a potent and selective human PPARa receptor agonist. In support of pre-clinical ADME studies and bioanalysis, three isotopomers of 2 have been synthesized. The results of these efforts are described below.
机译:尽管非诺贝特(la)可商购,并且在临床上可有效降低血清甘油三酯,但其活性和对PPARa受体的亚型选择性仅中等。因此,需要更有效和亚型的选择性PPARa激动剂。为此,发现工作已经确定了2-甲基-2-(4- [3- [1-(4-甲基苄基)-5-氧代-4,5-二氢-1H- [1,2,4]三唑- 3-基]丙基]苯氧基)丙酸(2),一种有效的选择性人PPARa受体激动剂。为了支持临床前ADME研究和生物分析,已合成了3种2的同位素。这些努力的结果描述如下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号